Shree Ganesh Biotech shareholders approve FY26 accounts, re-appoint Patel

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Shareholders adopted FY26 audited financial statements with 94.90% votes in favor
  • Aman Patel re-appointed as director with 94.77% support from polled votes
  • Total votes polled across both resolutions stood at 6,740,997
  • AGM held on September 28, 2026, at registered office in Kolkata
powered bylight_fuzz_icon
52147561

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Biotech (India) Limited shareholders adopted the audited financial statements for the fiscal year ended March 31, 2026, during the company's 16th Annual General Meeting (AGM). The meeting, held on September 28, 2026, also saw the re-appointment of Aman Patel as a director retiring by rotation.

The AGM commenced at 3:00 pm and concluded at 3:30 pm at the company's registered office in Kolkata. All proposed resolutions were passed by the shareholders present at the meeting. Voting results indicate strong support for both agenda items, with approximately 95% of polled votes cast in favor.

Key resolutions and voting outcomes

The following ordinary resolutions were transacted and approved by the shareholders:

  • Adoption of FY26 financials: The audited financial statements for FY26, along with the reports of the Directors and Auditors, were adopted. A total of 6,740,997 votes were polled on this resolution. Of these, 6,397,489 votes were in favor (94.90%) and 343,508 were against (5.10%).
  • Re-appointment of Director: Aman Patel (DIN: 08483544) was re-appointed as a director retiring by rotation. The same number of total votes (6,740,997) was polled, with 6,388,669 votes in favor (94.77%) and 352,328 against (5.23%).

The voting process included both remote e-voting and physical poll facilities. For the financial statements adoption, 192 members voted in favor via e-voting, while 1 member voted in favor via poll. For the director's re-appointment, 186 members voted in favor via e-voting, and 1 via poll.

Compliance and meeting details

The proceedings were conducted in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details regarding the voting results, as required under Regulation 44(3) of the Listing Regulations, were submitted separately to the stock exchanges.

Event Date Time Location
16th Annual General Meeting September 28, 2026 3:00 pm - 3:30 pm Registered Office, Kolkata

The filing was signed by Aman Patel, Whole-Time Director, confirming the outcome of the meeting. The scrutinizer's report, prepared by Daksha Negi & Associates, confirmed that no invalid or incomplete votes were found in the e-voting system.

Historical Stock Returns for Shree Ganesh Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-2.13%-4.17%-8.00%-16.36%-40.26%0.0%

How does Shree Ganesh Biotech's FY26 financial performance compare to its FY25 results and industry peers?

What specific strategic initiatives or capital expenditure plans were outlined in the Director's Report adopted during the AGM?

Will the re-appointment of Aman Patel lead to any changes in the company's governance structure or operational leadership?

like18
dislike

Shree Ganesh Bio-Tech schedules 16th AGM for September 28

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Shree Ganesh Bio-Tech will hold its 16th AGM on September 28, 2026, in Kolkata
  • Audited financial statements for FY26 ending March 31, 2026, will be adopted
  • Aman Patel seeks re-appointment as director after retiring by rotation
  • Remote e-voting runs from September 25 to September 27, 2026
  • The register of members closes from September 21 to September 28, 2026
powered bylight_fuzz_icon
49961752

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Bio-Tech has scheduled its 16th Annual General Meeting for Monday, September 28, 2026. The meeting will be held at the company’s registered office in Kolkata at 3:00 pm.

The primary agenda includes receiving, considering, and adopting the audited financial statements for the fiscal year ended March 31, 2026. Shareholders will also vote on the re-appointment of Aman Patel as a director, who retires by rotation.

Meeting Details and Agenda

The notice, issued under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, outlines the ordinary business to be transacted. The Board of Directors’ report and Independent Auditors’ report for FY26 will be presented alongside the financial statements.

Director Re-appointment

Aman Patel, who holds DIN 08483544, seeks re-appointment as a whole-time director. He was originally appointed on March 21, 2020, and brings expertise in operations and general management. According to the explanatory statement, he holds nil shares in the company as of March 31, 2025, and drew nil remuneration in the last period.

Director Detail Information
Name Aman Patel
DIN 08483544
Date of Birth March 29, 1998
Expertise Operations and General Management
Shares Held (as of March 31, 2025) Nil
Remuneration Last Drawn Nil

Voting and Record Dates

Remote e-voting through the NSDL system will begin on Friday, September 25, 2026, at 9:00 am and conclude on Sunday, September 27, 2026, at 5:00 pm. The record date for determining voting eligibility is Monday, September 21, 2026.

The Register of Members and Share Transfer Register will remain closed from September 21, 2026, to September 28, 2026, both days inclusive. Members are advised to submit any queries regarding accounts or operations at least seven days before the meeting.

E-Voting Instructions

Individual shareholders holding securities in demat mode can vote via their depository accounts with NSDL or CDSL. Those holding physical shares must use their EVEN number and folio number for login credentials. Institutional shareholders are required to submit scanned copies of board resolutions authorizing their representatives to vote.

Members whose email addresses are not registered with the depositories must provide necessary documents, including PAN and Aadhaar cards, to the company via email to procure user IDs and passwords for e-voting.

Historical Stock Returns for Shree Ganesh Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-2.13%-4.17%-8.00%-16.36%-40.26%0.0%

How will the adoption of FY26 audited financial statements reflect Shree Ganesh Bio-Tech's operational performance and profitability trends?

What strategic initiatives is Aman Patel expected to prioritize in operations and general management following his re-appointment as a whole-time director?

Given that Aman Patel holds nil shares and drew nil remuneration, what are the implications for executive compensation structures and shareholder alignment at the company?

like17
dislike

More News on Shree Ganesh Bio-Tech

1 Year Returns:-40.26%